Participants who fully adhered to treatment lost an average of 16.6% of their body weight
In the meantime, healthcare providers and patients must work together to weigh the benefits and risks associated with this medication during pregnancy
doi: 10.1073/pnas.94.26.14243
Researched for Preclinical (mouse-only) metabolic research as a selective inhibitor of NNMT (nicotinamide N-methyltransferase)
Lv M, Xue G, Cheng H, et al
Studies have shown that taking 1,000 mg/day of Setria can lead to a 30% increase in whole blood, a 35% increase in red blood cells, and a 260% increase in buccal cells glutathione levels, all without adversely affecting the bodys normal production of glutathione.